FDA — authorised 27 November 2013
- Application: NDA205109
- Marketing authorisation holder: VIFOR FRESENIUS
- Local brand name: VELPHORO
- Indication: TABLET, CHEWABLE — ORAL
- Status: approved
🇺🇸 PA21 in United States
FDA authorised PA21 on 27 November 2013
Marketing authorisation
Other Diabetes approved in United States
Frequently asked questions
Is PA21 approved in United States?
Yes. FDA authorised it on 27 November 2013.
Who is the marketing authorisation holder for PA21 in United States?
VIFOR FRESENIUS holds the US marketing authorisation.